PAHC 株価分析 — PHIBRO ANIMAL HEALTH CORPORATION (Healthcare >> Drug Manufacturers - Specialty & Generic)
PAHC に関するよくある質問
PAHCのPER(株価収益率)は?
PHIBRO ANIMAL HEALTH CORPORATION(PAHC)は現在PER 15.53倍で取引されています。
PAHCのROE(自己資本利益率)は?
PHIBRO ANIMAL HEALTH CORPORATIONのROEは26.32%です。
PAHCの配当利回りは?
PHIBRO ANIMAL HEALTH CORPORATIONの配当利回りは1.30%です。
PAHCの品質スコア(Quality Score)は?
当社のAIはPAHCの総合財務品質を100点中77点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
PAHCは今が買い時ですか?
当社AIのタイミングスコアは100点中51点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
PAHCはどのセクターに属しますか?
PHIBRO ANIMAL HEALTH CORPORATIONはHealthcare >> Drug Manufacturers - Specialty & Genericセクターに分類されます(NASDAQ市場)
PAHC AI Analysis Summary
Our AI summary for PAHC: PHIBRO ANIMAL HEALTH CORPORATION (NASDAQ), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 15.53, ROE of 26.32%, a dividend yield of 1.30%. Its financial Quality Score stands at 77/100 — mid-range fundamentals relative to the market. The AI Timing Score is 51/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 36.33
Price
-0.12
(-0.33%)
Day Change
|
|
|---|
PAHC, ファンダメンタルスコアはgood ( ファンダメンタル = 77) but テクニカルスコアは ...(Sign In to See)...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
ROAがROEに比べて低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
52% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 97 |
| Magic Formula Rank by ROA |
1515
|
| Magic Formula Rank by ROE |
1515
|
| Magic Formula Rank by ROIC |
801
|
| Price | 36.33 |
| PBV / Sector |
4.09 / 3.22
|
| Earning Per Share | 2.34 |
| PE / Sector |
15.53 / 29.79
|
| PEG or PE/Growth / Sector |
N/A / 0.13
|
| Average 1M Daily Value |
8.68 M
|
| Average 1W Daily Value |
8.51 M
|
| Timing Factors |
|
42% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
62% |
| 配当 |
|
12% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:18 |
| Symbol | PAHC |
| Name | PHIBRO ANIMAL HEALTH CORPORATION |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NASDAQ |
| Listed Shares | 21.07 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,478.58 / 10,754.62 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712
Phone: 201 329 7300
Website: https://www.pahc.com
Employees: 2,475
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
Google